Building the Future of Chronic Disease Care

By Momo Yamamoto, Senior Investor Research Analyst, LSN

Chronic diseases represent one of healthcare’s greatest challenges and one of its largest opportunities for innovation. As the global burden of chronic conditions continues to grow, investors are looking for solutions that can improve outcomes, reduce long-term costs, and fundamentally change how patients manage their health.

At RESI Boston, the panel Building the Future of Chronic Disease Care: Innovation Across Therapeutics, Devices, and Digital Health will bring together investors to discuss where they see the most compelling opportunities across the chronic disease landscape.

The conversation will explore innovation across therapeutics, medical devices, diagnostics, and digital health, as well as the evolving reimbursement and adoption models that can determine whether a promising technology successfully reaches patients. Panelists will also share what they look for when evaluating early-stage companies, from clinical and commercial validation to differentiation, scalability, and a clear path to market.

Chronic Disease Panelists
Soyoung Park 1004 Venture Partners (Moderator)	Gopal Chopra Validare Capital	Navin Govind Evidence Ventures
Nune Martiros Paladin Capital Group	John Tremblay Launchpad Venture Group

For early-stage founders developing solutions for chronic disease, this session offers an opportunity to hear directly from investors about what is attracting capital today and what companies need to demonstrate to stand out in a large and increasingly competitive market.

Join the conversation at RESI Boston, September 22–23 at the Westin Copley Place, and connect with investors, strategic partners, and fellow innovators advancing the next generation of healthcare.